NASDAQ:AEZS
Delisted

Aeterna Zentaris Stock News

etoro logo Buy AEZS
*Your capital is at risk
$5.72
+0 (+0%)
At Close: Nov 13, 2024
The offering is expected to result in gross proceeds to Aeterna Zentaris of approximately $4.5 million. Aeterna Zentaris will also issue to the purchasers unregistered warrants to purchase up to an a
As part of his presentation, Dr. Paulini will provide a corporate overview and update on the Company’s lead product, Macrilen™ (macimorelin), the only U.S. FDA and European Commission approved ora
– Study P01 is the first of two studies as agreed with the EMA in the Company’s Pediatric Investigation Plan for macimorelin as a growth hormone deficiency diagnostic – – Study.
CHARLESTON, S.C., Jan. 27, 2020 -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company engaged in.

64 Biggest Movers From Yesterday

12:00am, Friday, 10'th Jan 2020
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 8.) Allergan plc (NYSE: AGN ): AbbVie Inc (
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 17) Acceleron Pharma Inc (NASDAQ: XLRN ) Allergan plc
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE